Trevi Therapeutics revenue

Trevi Therapeutics revenue increased from $6.1 million in 2017 to $14.1 million in 2018, a 130.9% increase.

Annual Revenue ($)

Trevi Therapeutics revenue was $14.07 m in FY, 2018 which is a 130.9% year over year increase from the previous period.

FY, 2017FY, 2018
Revenue$6.10 m$14.07 m
Growth130.88%